Absci to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
31 December 2021 - 12:05AM
Absci Corporation (Nasdaq: ABSI), the drug and target discovery
company harnessing deep learning AI and synthetic biology to expand
the therapeutic potential of proteins, today announced the company
will be participating in the H.C. Wainwright BIOCONNECT Virtual
Conference.
Absci’s management is scheduled to present on
Monday, January 10th at 4:00 a.m. Pacific Time / 7:00 a.m. Eastern
Time. Interested parties may access a live and archived webcast of
the presentation on the “Investors” section of the company website
via www.absci.com.
About Absci
Absci is the drug and target discovery company
harnessing deep learning and synthetic biology to expand the
therapeutic potential of proteins. We built our Integrated Drug
Creation™ Platform to identify novel drug targets, discover optimal
biotherapeutic candidates, and generate the cell lines to
manufacture them in a single efficient process. Biotech and pharma
innovators partner with us to create the next generation of
protein-based drugs, including those that may be impossible to make
with other technologies. Our goal is to enable the development of
better medicines by Translating Ideas into Drugs™. For
more information visit www.absci.com and follow us on social media:
Twitter: @Abscibio, LinkedIn: @absci.
Availability of Other Information about
Absci
Investors and others should note that we routinely
communicate with investors and the public using our website
(www.absci.com) and the “Investors” section of our website
(investors.absci.com), including without limitation, through the
posting of investor presentations, SEC filings, press releases,
public conference calls and webcasts on these websites. The
information that we post on these websites could be deemed to be
material information. As a result, investors, the media, and others
interested in Absci are encouraged to review this information on a
regular basis. The contents of our website, or any other website
that may be accessed from our website, shall not be deemed
incorporated by reference in any filing under the Securities Act of
1933, as amended.
Investor Contact
investors@absci.com
Media Contact
press@absci.com
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From Apr 2023 to Apr 2024